First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice

Naito R, Izumi K, Mizokami A

Transl Androl Urol 2020;9(3):986-990 　doi: 10.21037/tau.2020.04.08